Developing mRNA for therapy – Not Warp Speed – Reichstein Award Lecture 2021 by Prof. Dr. Dr. h.c. Katalin Karikó – September 6, 2021
It is the stated goal ofSAPhSto promote pharmaceutical sciences and scientists. This includes promoting their perception and recognition among the population. The awarding of the Reichstein Medal should contribute to this. It is reminiscent of the merits of the Swiss chemist and Nobel Prize winner Tadeus Reichstein, who developed the synthesis of ascorbic acid (vitamin C) in 1932 and thus made its industrial production possible. The Reichstein Medal is awarded by the SAPhS to internationally recognized personalities who have made a direct or indirect special interest in promoting pharmaceutical sciences in the fields of research, teaching and practice.
Prof. Dr. Dr. h.c. Katalin Karikó
This year, SAPhW honors with the Reichstein MedalProf. Dr. Dr. h.c.. Katalin Karikófor her contributions to the development of mRNA technology. For a long time, this technology was not considered suitable for drug and vaccine development. It is thanks to the tireless work of pioneers like Prof. Karikó, carried out against great odds and with tenacity, that pandemic mRNA vaccines have become a reality today.
Developing mRNA for therapy – Not Warp Speed
Presentation by Katalin Karikó, PhD Adj. Professor of Neurosurgery, University of Pennsylvania Perelman School of Medicine– Senior Vice President, BioNTech RNA Pharmaceuticals – September 6, 2021 Reichstein Medal Lecture
until December 31, 2021. Further information is also availableReichstein Medal 2021 – Retrospect | Swiss Academy of Pharmaceutical Sciences SAPhS (saphw.ch)
What are the Ingredients and Excipients in the COVID-19 Vaccines?